Microbot Medical
MBOTMicrobot Medical is a clinical-stage medical device company developing next-generation robotic platforms for minimally invasive endoluminal surgery.
Earnings
Next report
Aug 11, 2026 (in a month)Valuation & ratios
Competitors
By market cap
By revenue growth
By net margin
Profile
Microbot Medical is a clinical-stage medical device company developing next-generation robotic platforms for minimally invasive endoluminal surgery. The company's core value proposition is the creation of compact, fully disposable robotic systems that improve surgical outcomes, reduce physician radiation exposure, and eliminate the need for expensive, dedicated capital equipment in catheterization labs.
Microbot is a pioneer in the fully disposable endovascular robotics niche, positioning itself as a lower-cost, mobile alternative to traditional heavy-capital robotic systems.
Questions, answered.
- What is Microbot Medical's market cap?
- Microbot Medical (MBOT) has a market capitalization of $124.9M and trades on NASDAQ.
- What is Microbot Medical's revenue and profitability?
- Microbot Medical generated $190.2K in trailing twelve-month revenue with a net loss of $14.2M, representing a net margin of -3669.9%, with free cash flow of -$15.4M. These figures are based on the Q1 2026 filing.
- Who are Microbot Medical's competitors?
- Microbot Medical's key competitors include Medtronic, Intuitive Surgical, Integer Holdings Corporation, and others. These companies compete in similar markets and product categories.
- Who does Microbot Medical partner with?
- Microbot Medical's notable partners include Corewell Health, Emory University, The Technion Research and Development Foundation Ltd., and others.
- What subsidiaries does Microbot Medical have?
- Microbot Medical's subsidiaries include Microbot Medical Ltd..
- Where is Microbot Medical headquartered?
- Microbot Medical is headquartered in United States of America and employs approximately 22 people. It has been publicly traded since 1992.
